Navigation Links
NDI Announces New Healthcare Venture Fund
Date:1/31/2011

CLEVELAND, Jan. 31, 2011 /PRNewswire/ -- NDI has launched the NDI Healthcare Fund, a new commercialization fund focused on developing innovative neurodevice technologies.  The Fund recently raised $8 million from equity investments and a grant from the State of Ohio.

(Logo: http://photos.prnewswire.com/prnh/20110131/DC38962LOGO)

"The NDI Healthcare Fund will invest in both seed-stage neurodevice companies and technologies," said Geoff Thrope, NDI's CEO, founder and president. "We are looking for product opportunities in large markets where there is at least one validated product, but where critical clinical needs still exist."

NDI is a leader in commercializing innovative neurodevice technologies to address significant unmet health conditions, improve patients' lives, and provide significant returns to investors.  Over the past decade, NDI's team of neurodevice entrepreneurs, scientists and professionals has developed products to restore lost neurological function, prevent damage, and reduce the effects of disease and injury.  

In April 2008, NDI sold its MEDSTIM urinary incontinence system to Medtronic for $42 million.  

Since then, the company has raised an additional $15 million in private equity and another $7 million in grants and loans from the State of Ohio's Third Frontier Program and the NIH.  

NDI invests these funds in its unique platform of technologies, pipeline of commercialization opportunities, and portfolio companies, including Checkpoint Surgical and SPR™ Therapeutics.  

Checkpoint Surgical provides physicians with medical devices to locate, evaluate and preserve nerves and muscles in surgical procedures for better patient outcomes. SPR™ Therapeutics is developing patented nerve stimulation products for treating chronic and severe pain.

NDI maintains core capabilities under one roof -- including clinical and regulatory affairs, engineering and product development, operations and research -- to assess, develop and generate neurodevice products and companies. NDI is headquartered in Cleveland, Ohio, one of the world's leading centers of neurodevice research and innovation.

For more information on NDI, please contact Jackie Greiner at (216) 378-9106, ext. 117 or email at jgreiner@ndimedical.com.


'/>"/>
SOURCE NDI
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests
2. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
3. Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
4. Endologix Announces Favorable Clinical Results for Nellix Technology
5. Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II
6. Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments
7. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
8. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
9. Physiotherapy Associates Announces New Clinic in Castle Rock, CO
10. Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results
11. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Tie-up with Government hospitals as ... to save newborns   Fortis La Femme, ... collaboration with Breast Milk Foundation (BMF), a non-profit organization within ... Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that ... and should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, ... of Jennifer Hagerman , Pharm D., to Vice ... growing role at Diplomat, Hagerman will continue to lead ... company that delivers custom education and training to Diplomat ... specialty pharmacy industry. Diplomat University also houses the quality ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is now ... as more patients are discovering the many different ways they can change and improve ... to them and which ones might work for their smiles. , “One of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... Newport Beach, CA (PRWEB) , ... April 29, 2016 , ... ... Dr. Jane L. Frederick, Dr. Sanaz Ghazal, and Dr. Daniel A. Potter -- are ... the Society for Assisted Reproductive Technology (SART). In April, SART published the ...
Breaking Medicine News(10 mins):